The immune‐related role of BRAF in melanoma

Mostrar otras versiones (1)

BACKGROUND: The existence of a dichotomy between immunologically active and quiescent tumor phenotypes has been recently recognized in several types of cancer. The activation of a Th1 type of immune signature has been shown to confer better prognosis and likelihood to respond to immunotherapy. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomei, Sara, Bedognetti, Davide, De Giorgi, Valeria, Sommariva, Michele, Civini, Sara, Reinboth, Jennifer, Al Hashmi, Muna, Ascierto, Maria Libera, Liu, Qiuzhen, Ayotte, Ben D., Worschech, Andrea, Uccellini, Lorenzo, Ascierto, Paolo A., Stroncek, David, Palmieri, Giuseppe, Chouchane, Lotfi, Wang, Ena, Marincola, Francesco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2014
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500792/
https://www.ncbi.nlm.nih.gov/pubmed/25174651
http://dx.doi.org/10.1016/j.molonc.2014.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500792/
https://www.ncbi.nlm.nih.gov/pubmed/25174651
http://dx.doi.org/10.1016/j.molonc.2014.07.014

Ejemplares similares